Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar 28:2022:7375006.
doi: 10.1155/2022/7375006. eCollection 2022.

Impact of High-Flux Hemodialysis on Chronic Inflammation, Antioxidant Capacity, Body Temperature, and Immune Function in Patients with Chronic Renal Failure

Sufang Li  1 , Hongwei Li  2 , Jun Wang  3 , Lianliang Yin  1
Affiliations
Randomized Controlled Trial

Impact of High-Flux Hemodialysis on Chronic Inflammation, Antioxidant Capacity, Body Temperature, and Immune Function in Patients with Chronic Renal Failure

Sufang Li et al. J Healthc Eng. .

Retraction in

Abstract

In order to probe into the impact of high-flux dialysis and hemodiafiltration on patients with chronic rental failure, this paper selects in total 92 cases with chronic renal failure receiving hemodialysis from November 2018 to July 2021, allocating them into two groups based on the random table, each with 46 cases. The control group received hemodiafiltration, the observation group is given high-flux hemodialysis, and we compared serum inflammatory factor level and antioxidant factor level before and after treatment, as well as cellular immune factor level (CD3+, CD4+) and humoral immune factor level (IgE) before and after treatment in the two groups; the renal function, serum total calcium ion level, and serum phosphorus ion level in the two groups were compared before and after treatment, as well as the proportion of metabolic abnormalities in calcium and phosphorus ion levels during treatment; the trend of changes in axillary temperature during treatment in the two groups is analyzed. After treatment, serum inflammatory factor level (hs-CRP & TNF-α) is lower than that in the control group (P < 0.05), antioxidant factor level (MDA) is lower than that in the control group (P < 0.05), and SOD level is higher than that in the control group (P < 05). After treatment CD3+ and CD4+ levels in the observation group are higher than those in the control group (P < 0.05). For patients with chronic renal failure, high-flux hemodialysis is available to better reduce inflammatory response, improve antioxidant and immune capacity in the body, and help maintain calcium and phosphorus metabolic balance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Comparison of serum inflammatory factor and antioxidant factor levels before and after treatment.
Figure 2
Figure 2
Comparison of CD3+, CD4+ levels, and humoral immune factor IgE level before and after treatment.
Figure 3
Figure 3
Comparison of renal function before and after treatment between the two groups.
Figure 4
Figure 4
Axillary temperature in the two groups during treatment.
See this image and copyright information in PMC

References

    1. Bridoux F., Carron P.-L., Pegourie B., et al. Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: a randomized clinical trial. JAMA . 2017;318(21):2099–2110. doi: 10.1001/jama.2017.17924. - DOI - PMC - PubMed
    1. Naka T., Haase M., Bellomo R. Super high-flux’or ‘high cut-Off’Hemofiltration and hemodialysis. Acute Blood Purification . 2010;166:181–189. doi: 10.1159/000314871. - DOI - PubMed
    1. Knehtl M., Jakopin E., Dvorsak B., Bevc S., Ekart R., Hojs R. The effect of high‐flux hemodialysis and post‐dilution hemodiafiltration on platelet closure time in patients with end stage renal disease. Hemodialysis International . 2019;23(3):319–324. doi: 10.1111/hdi.12756. - DOI - PubMed
    1. Morena M., Jaussent A., Chalabi L., et al. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney International . 2017;91(6):1495–1509. doi: 10.1016/j.kint.2017.01.013. - DOI - PubMed
    1. Kasama R., Koch T., Canals-Navas C., Pitone J. M. Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature. American Journal of Kidney Diseases . 1996;27(5):680–686. doi: 10.1016/s0272-6386(96)90103-1. - DOI - PubMed

Publication types